{"id":"W4205274612","doi":"10.1016/j.xcrm.2021.100506","title":"MEK inhibition invigorates chemoimmunotherapy by tumor mitophagy-induced CXCL10 expression","year":2022,"lang":"en","type":"letter","venue":"Cell Reports Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute, Cairo University; Takeda Pharmaceuticals U.S.A.; Sanofi; Astellas Pharma US; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company","keywords":"Cancer research; Chemoimmunotherapy; Medicine; Cancer; MEK inhibitor; MAPK/ERK pathway; Internal medicine; Immunotherapy; Biology; Kinase; Cell biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008886968,0.0009056574,0.001561092,0.0004704138,0.0003037111,0.00003661606,0.0002103412,0.0007851883,0.01463538],"category_scores_gemma":[0.0001203168,0.0007098072,0.0004233874,0.0006045463,0.000331166,0.0001219201,0.0001012047,0.002928186,0.00001929383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006528035,"about_ca_system_score_gemma":0.0004736859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004469006,"about_ca_topic_score_gemma":0.000001567125,"domain_scores_codex":[0.9942173,0.000186816,0.001742477,0.001316046,0.001778695,0.000758642],"domain_scores_gemma":[0.9961562,0.0001712331,0.001688143,0.001576823,0.0002121923,0.0001954106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000533546,0.0001000569,0.00005897992,0.0003591712,0.00009747859,0.008675974,0.0002391402,7.562103e-8,0.4461884,4.125146e-8,0.5427786,0.0009685706],"study_design_scores_gemma":[0.002960362,0.001156275,0.0000505467,0.0009612979,0.0001923461,0.002061055,0.0002014376,0.0000016203,0.3052958,0.00003249949,0.6866063,0.0004804916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.1808885,0.05545428,0.00005237207,0.7267879,0.01018168,0.004389234,0.00009529224,0.0007726227,0.02137808],"genre_scores_gemma":[0.03205404,0.002616516,0.0001281068,0.8990546,0.008335551,0.00058529,0.01020317,0.0004596674,0.04656304],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1722667,"threshold_uncertainty_score":0.9995353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01590015017601759,"score_gpt":0.255251365299526,"score_spread":0.2393512151235084,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}